An Enhanced Butyrylcholinesterase Method to Measure Organophosphorus Nerve Agent Exposure in Humans

Overview

Journal Anal Bioanal Chem

Specialty Chemistry

Date 2014 Mar 8

PMID 24604326

Citations 21

Authors

Brooke G Pantazides

Caroline M Watson

Melissa D Carter

Brian S Crow

Jonas W Perez

Thomas A Blake

Jerry D Thomas

Rudolph C Johnson

Affiliations

Soon will be listed here.

Abstract

Organophosphorus nerve agent (OPNA) adducts to butyrylcholinesterase (BChE) can be used to confirm exposure in humans. A highly accurate method to detect G- and V-series OPNA adducts to BChE in 75 μL of filtered blood, serum, or plasma has been developed using immunomagnetic separation (IMS) coupled with liquid chromatography tandem mass spectrometry (LC-MS/MS). The reported IMS method captures > 88 % of the BChE in a specimen and corrects for matrix effects on peptide calibrators. The optimized method has been used to quantify baseline BChE levels (unadducted and OPNA-adducted) in a matched-set of serum, plasma, and whole blood (later processed in-house for plasma content) from 192 unexposed individuals to determine the interchangeability of the tested matrices. The results of these measurements demonstrate the ability to accurately measure BChE regardless of the format of the blood specimen received. Criteria for accepting or denying specimens were established through a series of sample stability and processing experiments. The results of these efforts are an optimized and rugged method that is transferrable to other laboratories and an increased understanding of the BChE biomarker in matrix.

Citing Articles

Unambiguous identification and determination of A234-Novichok nerve agent biomarkers in biological fluids using GC-MS/MS and LC-MS/MS.

Mirbabaei F, Mohammad-Khah A, Naseri M, Babri M, Faraz S, Hosseini S Anal Bioanal Chem. 2022; 414(11):3429-3442.

PMID: 35190842 DOI: 10.1007/s00216-022-03964-1.

Poisoning by organophosphorus nerve agents and pesticides: An overview of the principle strategies and current progress of mass spectrometry-based procedures for verification.

John H, Thiermann H J Mass Spectrom Adv Clin Lab. 2021; 19:20-31.

PMID: 34820662 PMC: 8601002. DOI: 10.1016/j.jmsacl.2021.01.002.

Untargeted and targeted analysis of sarin poisoning biomarkers in rat urine by liquid chromatography and tandem mass spectrometry.

Vokuev M, Baygildiev T, Plyushchenko I, Ikhalaynen Y, Ogorodnikov R, Solontsov I Anal Bioanal Chem. 2021; 413(28):6973-6985.

PMID: 34549323 DOI: 10.1007/s00216-021-03655-3.

Identification and Study of Biomarkers from Novichok-Inhibited Butyrylcholinesterase in Human Plasma.

Jeong W, Lee J, Lim K, Kim H Molecules. 2021; 26(13).

PMID: 34206601 PMC: 8270327. DOI: 10.3390/molecules26133810.

The Effects of Gamma Irradiation on Chemical Biomarker Recovery from Mixed Chemical/Biological Threat Exposure Specimens.

Isenberg S, Carter M, Moon J, Laughlin S, Petway M, Mojica M J Appl Lab Med. 2020; 5(2):273-280.

PMID: 32445395 PMC: 9022197. DOI: 10.1093/jalm/jfz022.

References

Williams N, Harrison J, Read R, Black R . Phosphylated tyrosine in albumin as a biomarker of exposure to organophosphorus nerve agents. Arch Toxicol. 2007; 81(9):627-39. DOI: 10.1007/s00204-007-0191-8. View

Knaack J, Zhou Y, Abney C, Jacob J, Prezioso S, Hardy K . A high-throughput diagnostic method for measuring human exposure to organophosphorus nerve agents. Anal Chem. 2012; 84(21):9470-7. DOI: 10.1021/ac302301w. View

Caudill S, Schleicher R, Pirkle J . Multi-rule quality control for the age-related eye disease study. Stat Med. 2008; 27(20):4094-106. DOI: 10.1002/sim.3222. View

Black R . History and perspectives of bioanalytical methods for chemical warfare agent detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2009; 878(17-18):1207-15. DOI: 10.1016/j.jchromb.2009.11.025. View

Carter M, Crow B, Pantazides B, Watson C, deCastro B, Thomas J . Profiling cholinesterase adduction: a high-throughput prioritization method for organophosphate exposure samples. J Biomol Screen. 2013; 19(2):325-30. PMC: 5713889. DOI: 10.1177/1087057113497799. View

Westgard J, Barry P, Hunt M, Groth T . A multi-rule Shewhart chart for quality control in clinical chemistry. Clin Chem. 1981; 27(3):493-501. View

Nagao M, TAKATORI T, Matsuda Y, Nakajima M, Iwase H, Iwadate K . Definitive evidence for the acute sarin poisoning diagnosis in the Tokyo subway. Toxicol Appl Pharmacol. 1997; 144(1):198-203. DOI: 10.1006/taap.1997.8110. View

Ellman G, COURTNEY K, ANDRES Jr V, FEATHER-STONE R . A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961; 7:88-95. DOI: 10.1016/0006-2952(61)90145-9. View

Li B, Ricordel I, Schopfer L, Baud F, Megarbane B, Nachon F . Detection of adduct on tyrosine 411 of albumin in humans poisoned by dichlorvos. Toxicol Sci. 2010; 116(1):23-31. PMC: 2886864. DOI: 10.1093/toxsci/kfq117. View

10.

Sporty J, Lemire S, Jakubowski E, Renner J, Evans R, Williams R . Immunomagnetic separation and quantification of butyrylcholinesterase nerve agent adducts in human serum. Anal Chem. 2010; 82(15):6593-600. DOI: 10.1021/ac101024z. View

11.

Carter M, Crow B, Pantazides B, Watson C, Thomas J, Blake T . Direct quantitation of methyl phosphonate adducts to human serum butyrylcholinesterase by immunomagnetic-UHPLC-MS/MS. Anal Chem. 2013; 85(22):11106-11. PMC: 5713886. DOI: 10.1021/ac4029714. View

12.

Degenhardt C, Pleijsier K, van der Schans M, Langenberg J, Preston K, Solano M . Improvements of the fluoride reactivation method for the verification of nerve agent exposure. J Anal Toxicol. 2004; 28(5):364-71. DOI: 10.1093/jat/28.5.364. View

13.

Fidder A, Hulst A, Noort D, de Ruiter R, van der Schans M, Benschop H . Retrospective detection of exposure to organophosphorus anti-cholinesterases: mass spectrometric analysis of phosphylated human butyrylcholinesterase. Chem Res Toxicol. 2002; 15(4):582-90. DOI: 10.1021/tx0101806. View

14.

Adams T, Capacio B, Smith J, Whalley C, Korte W . The application of the fluoride reactivation process to the detection of sarin and soman nerve agent exposures in biological samples. Drug Chem Toxicol. 2004; 27(1):77-91. DOI: 10.1081/dct-120027901. View

15.

Nicolet Y, Lockridge O, Masson P, Fontecilla-Camps J, Nachon F . Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products. J Biol Chem. 2003; 278(42):41141-7. DOI: 10.1074/jbc.M210241200. View

16.

Riches J, Morton I, Read R, Black R . The trace analysis of alkyl alkylphosphonic acids in urine using gas chromatography-ion trap negative ion tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2005; 816(1-2):251-8. DOI: 10.1016/j.jchromb.2004.11.039. View

17.

Worek F, Mast U, Kiderlen D, Diepold C, Eyer P . Improved determination of acetylcholinesterase activity in human whole blood. Clin Chim Acta. 1999; 288(1-2):73-90. DOI: 10.1016/s0009-8981(99)00144-8. View

18.

Aurbek N, Thiermann H, Eyer F, Eyer P, Worek F . Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis. Toxicology. 2009; 259(3):133-9. DOI: 10.1016/j.tox.2009.02.014. View

19.

Swaim L, Johnson R, Zhou Y, Sandlin C, Barr J . Quantification of organophosphorus nerve agent metabolites using a reduced-volume, high-throughput sample processing format and liquid chromatography-tandem mass spectrometry. J Anal Toxicol. 2008; 32(9):774-7. DOI: 10.1093/jat/32.9.774. View

20.

Li B, Nachon F, Froment M, Verdier L, Debouzy J, Brasme B . Binding and hydrolysis of soman by human serum albumin. Chem Res Toxicol. 2008; 21(2):421-31. DOI: 10.1021/tx700339m. View